GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR)
HDAC9_MOUSE Reviewed; 588 AA.
Q99N13; Q4QQN7; Q8R4Y6; Q9EPT2;
18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
20-MAR-2007, sequence version 2.
28-MAR-2018, entry version 147.
RecName: Full=Histone deacetylase 9;
Short=HD9;
EC=3.5.1.98;
AltName: Full=Histone deacetylase 7B;
Short=HD7b;
AltName: Full=Histone deacetylase-related protein;
AltName: Full=MEF2-interacting transcription repressor MITR;
Name=Hdac9; Synonyms=Hdac7b, Hdrp, Mitr;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), HOMODIMERIZATION, INTERACTION
WITH CTBP1; HDAC1; HDAC3; HDAC4 AND HDAC5, AND MUTAGENESIS OF
25-ASP-LEU-26.
STRAIN=NIH Swiss; TISSUE=Embryonic heart;
PubMed=11022042; DOI=10.1074/jbc.M007364200;
Zhang C.L., McKinsey T.A., Lu J.R., Olson E.N.;
"Association of COOH-terminal-binding protein (CtBP) and MEF2-
interacting transcription repressor (MITR) contributes to
transcriptional repression of the MEF2 transcription factor.";
J. Biol. Chem. 276:35-39(2001).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
STRAIN=Swiss Webster / NIH;
Zhou X., Richon V.M., Rifkind R.A., Marks P.A.;
"Cloning of the mouse HDRP cDNA.";
Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
STRAIN=C57BL/6J; TISSUE=Retina;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
FUNCTION, PHOSPHORYLATION AT SER-220 AND SER-450, TISSUE SPECIFICITY,
DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION.
PubMed=11390982; DOI=10.1073/pnas.131198498;
Zhang C.L., McKinsey T.A., Olson E.N.;
"The transcriptional corepressor MITR is a signal-responsive inhibitor
of myogenesis.";
Proc. Natl. Acad. Sci. U.S.A. 98:7354-7359(2001).
[5]
PHOSPHORYLATION AT SER-220 AND SER-450, FUNCTION, AND DISRUPTION
PHENOTYPE.
PubMed=12202037; DOI=10.1016/S0092-8674(02)00861-9;
Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A.,
Olson E.N.;
"Class II histone deacetylases act as signal-responsive repressors of
cardiac hypertrophy.";
Cell 110:479-488(2002).
[6]
PHOSPHORYLATION AT SER-240, AND SUBCELLULAR LOCATION.
PubMed=15546868; DOI=10.1074/jbc.M411894200;
Deng X., Ewton D.Z., Mercer S.E., Friedman E.;
"Mirk/dyrk1B decreases the nuclear accumulation of class II histone
deacetylases during skeletal muscle differentiation.";
J. Biol. Chem. 280:4894-4905(2005).
[7]
FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, DOWN-REGULATION BY
DENERVATION, INTERACTION WITH HDAC1 AND HDAC3, AND SUBCELLULAR
LOCATION.
PubMed=15711539; DOI=10.1038/nn1408;
Mejat A., Ramond F., Bassel-Duby R., Khochbin S., Olson E.N.,
Schaeffer L.;
"Histone deacetylase 9 couples neuronal activity to muscle chromatin
acetylation and gene expression.";
Nat. Neurosci. 8:313-321(2005).
[8]
DOWN-REGULATION BY NEURONAL APOPTOSIS, FUNCTION, AND INTERACTION WITH
HDAC1 AND MAPK10.
PubMed=16611996; DOI=10.1128/MCB.26.9.3550-3564.2006;
Morrison B.E., Majdzadeh N., Zhang X., Lyles A., Bassel-Duby R.,
Olson E.N., D'Mello S.R.;
"Neuroprotection by histone deacetylase-related protein.";
Mol. Cell. Biol. 26:3550-3564(2006).
[9]
INDUCTION BY MEF2, AND DEVELOPMENTAL STAGE.
PubMed=17101791; DOI=10.1128/MCB.01415-06;
Haberland M., Arnold M.A., McAnally J., Phan D., Kim Y., Olson E.N.;
"Regulation of HDAC9 gene expression by MEF2 establishes a negative-
feedback loop in the transcriptional circuitry of muscle
differentiation.";
Mol. Cell. Biol. 27:518-525(2007).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-552, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Brain;
PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
"A tissue-specific atlas of mouse protein phosphorylation and
expression.";
Cell 143:1174-1189(2010).
[11]
X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 139-158 IN COMPLEX WITH MEF2
AND DNA.
PubMed=15567413; DOI=10.1016/j.jmb.2004.10.033;
Han A., He J., Wu Y., Liu J.O., Chen L.;
"Mechanism of recruitment of class II histone deacetylases by myocyte
enhancer factor-2.";
J. Mol. Biol. 345:91-102(2005).
-!- FUNCTION: Devoided of intrinsic deacetylase activity, promotes the
deacetylation of lysine residues on the N-terminal part of the
core histones (H2A, H2B, H3 and H4) by recruiting HDAC1 and HDAC3.
Histone deacetylation gives a tag for epigenetic repression and
plays an important role in transcriptional regulation, cell cycle
progression and developmental events. Represses MEF2-dependent
transcription, inhibits skeletal myogenesis and may be involved in
heart development. Protects neurons from apoptosis, both by
inhibiting JUN phosphorylation by MAPK10 and by repressing JUN
transcription via HDAC1 recruitment to JUN promoter.
{ECO:0000269|PubMed:11390982, ECO:0000269|PubMed:12202037,
ECO:0000269|PubMed:15711539, ECO:0000269|PubMed:16611996}.
-!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
a histone to yield a deacetylated histone.
-!- SUBUNIT: Homodimer. Interacts with ETV6 (By similarity). Interacts
with MEF2, HDAC1, HDAC3, HDAC4, HDAC5, CTBP1 and MAPK10. The
phosphorylated form interacts with 14-3-3. Interacts with FOXP3 in
the absence of T-cell stimulation (By similarity).
{ECO:0000250|UniProtKB:Q9UKV0, ECO:0000269|PubMed:11022042,
ECO:0000269|PubMed:15567413, ECO:0000269|PubMed:15711539,
ECO:0000269|PubMed:16611996}.
-!- INTERACTION:
P60335:Pcbp1; NbExp=6; IntAct=EBI-645361, EBI-309059;
Q3TKT4:Smarca4; NbExp=3; IntAct=EBI-645361, EBI-1210244;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11390982,
ECO:0000269|PubMed:15546868, ECO:0000269|PubMed:15711539}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=3;
Name=1;
IsoId=Q99N13-1; Sequence=Displayed;
Name=2; Synonyms=Hdrpa;
IsoId=Q99N13-2; Sequence=VSP_023769;
Note=No experimental confirmation available.;
Name=3;
IsoId=Q99N13-3; Sequence=VSP_029173;
-!- TISSUE SPECIFICITY: Expressed at high levels in heart, brain and
spleen. Expressed in skeletal muscle.
{ECO:0000269|PubMed:11390982, ECO:0000269|PubMed:15711539}.
-!- DEVELOPMENTAL STAGE: At E10.5, expressed in heart, skeletal muscle
and neural lineages. At E11.5, expressed in heart, dorsal root
ganglia and neural tube. At E12.5, expressed in heart, skeletal
muscle, dorsal root ganglia, neural tube and retina. Strongly up-
regulated in muscle between E14 and E19 as a result of motor
innervation. {ECO:0000269|PubMed:11390982,
ECO:0000269|PubMed:15711539, ECO:0000269|PubMed:17101791}.
-!- INDUCTION: By MEF2 during muscle differentiation. Down-regulated
by muscle denervation. Down-regulated by trichostatin A or sodium
butyrate, and during neuronal apoptosis (at protein level).
{ECO:0000269|PubMed:17101791}.
-!- PTM: Sumoylated. {ECO:0000250}.
-!- PTM: Phosphorylated on Ser-220 and Ser-450; which promotes 14-3-3-
binding, impairs interaction with MEF2, and antagonizes
antimyogenic activity. Phosphorylated on Ser-240 by DYRK1B; which
impairs nuclear accumulation. Phosphorylated by the PKC kinases
PKN1 and PKN2, impairing nuclear import.
{ECO:0000269|PubMed:11390982, ECO:0000269|PubMed:12202037,
ECO:0000269|PubMed:15546868}.
-!- DISRUPTION PHENOTYPE: Mice do not present any abnormality at early
age but develop cardiac hypertrophy by eight months of age.
{ECO:0000269|PubMed:12202037}.
-!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
subfamily. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF324492; AAG48332.1; -; mRNA.
EMBL; AF235053; AAK15027.1; -; mRNA.
EMBL; AF279371; AAL86358.1; -; mRNA.
EMBL; BC098187; AAH98187.1; -; mRNA.
CCDS; CCDS36432.1; -. [Q99N13-1]
RefSeq; NP_077038.2; NM_024124.3.
UniGene; Mm.310551; -.
UniGene; Mm.483009; -.
PDB; 1TQE; X-ray; 2.70 A; X/Y=139-158.
PDBsum; 1TQE; -.
ProteinModelPortal; Q99N13; -.
SMR; Q99N13; -.
BioGrid; 219748; 9.
DIP; DIP-41905N; -.
ELM; Q99N13; -.
IntAct; Q99N13; 7.
STRING; 10090.ENSMUSP00000106443; -.
ChEMBL; CHEMBL3832944; -.
iPTMnet; Q99N13; -.
PhosphoSitePlus; Q99N13; -.
PaxDb; Q99N13; -.
PeptideAtlas; Q99N13; -.
PRIDE; Q99N13; -.
GeneID; 79221; -.
KEGG; mmu:79221; -.
UCSC; uc007nja.1; mouse. [Q99N13-3]
UCSC; uc007njb.1; mouse. [Q99N13-2]
UCSC; uc007njc.2; mouse. [Q99N13-1]
CTD; 9734; -.
MGI; MGI:1931221; Hdac9.
eggNOG; KOG1343; Eukaryota.
eggNOG; COG0123; LUCA.
HOGENOM; HOG000232065; -.
HOVERGEN; HBG057100; -.
InParanoid; Q99N13; -.
KO; K11409; -.
PhylomeDB; Q99N13; -.
TreeFam; TF106174; -.
EvolutionaryTrace; Q99N13; -.
PRO; PR:Q99N13; -.
Proteomes; UP000000589; Unplaced.
CleanEx; MM_HDAC9; -.
GO; GO:0005737; C:cytoplasm; ISO:MGI.
GO; GO:0000118; C:histone deacetylase complex; TAS:UniProtKB.
GO; GO:0035097; C:histone methyltransferase complex; IDA:BHF-UCL.
GO; GO:0005634; C:nucleus; ISO:MGI.
GO; GO:0005667; C:transcription factor complex; ISO:MGI.
GO; GO:0004407; F:histone deacetylase activity; TAS:UniProtKB.
GO; GO:0042826; F:histone deacetylase binding; ISO:MGI.
GO; GO:0033558; F:protein deacetylase activity; ISO:MGI.
GO; GO:0005080; F:protein kinase C binding; ISO:MGI.
GO; GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL.
GO; GO:0003714; F:transcription corepressor activity; IDA:MGI.
GO; GO:0008134; F:transcription factor binding; ISO:MGI.
GO; GO:0042113; P:B cell activation; TAS:UniProtKB.
GO; GO:0030183; P:B cell differentiation; TAS:UniProtKB.
GO; GO:0032869; P:cellular response to insulin stimulus; ISO:MGI.
GO; GO:0006325; P:chromatin organization; TAS:UniProtKB.
GO; GO:0007507; P:heart development; IGI:MGI.
GO; GO:0016575; P:histone deacetylation; ISO:MGI.
GO; GO:0070932; P:histone H3 deacetylation; ISO:MGI.
GO; GO:0070933; P:histone H4 deacetylation; ISO:MGI.
GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
GO; GO:0045843; P:negative regulation of striated muscle tissue development; TAS:UniProtKB.
GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI.
GO; GO:0007399; P:nervous system development; TAS:UniProtKB.
GO; GO:0034983; P:peptidyl-lysine deacetylation; ISO:MGI.
GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISO:MGI.
GO; GO:0048742; P:regulation of skeletal muscle fiber development; IGI:MGI.
GO; GO:0051153; P:regulation of striated muscle cell differentiation; IGI:MGI.
GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
InterPro; IPR024643; Hist_deacetylase_Gln_rich_N.
Pfam; PF12203; HDAC4_Gln; 1.
1: Evidence at protein level;
3D-structure; Alternative splicing; Chromatin regulator;
Complete proteome; Hydrolase; Nucleus; Phosphoprotein;
Reference proteome; Repressor; Transcription;
Transcription regulation; Ubl conjugation.
CHAIN 1 588 Histone deacetylase 9.
/FTId=PRO_0000114711.
REGION 23 27 Interaction with CTBP1.
{ECO:0000269|PubMed:11022042}.
REGION 136 154 Interaction with MEF2.
REGION 175 343 Interaction with MAPK10.
{ECO:0000269|PubMed:16611996}.
REGION 218 261 Interaction with ETV6. {ECO:0000250}.
MOD_RES 22 22 Phosphoserine.
{ECO:0000250|UniProtKB:Q9UKV0}.
MOD_RES 220 220 Phosphoserine.
{ECO:0000269|PubMed:11390982,
ECO:0000269|PubMed:12202037}.
MOD_RES 240 240 Phosphoserine; by DYRK1B.
{ECO:0000269|PubMed:15546868}.
MOD_RES 450 450 Phosphoserine.
{ECO:0000269|PubMed:11390982,
ECO:0000269|PubMed:12202037}.
MOD_RES 552 552 Phosphoserine.
{ECO:0000244|PubMed:21183079}.
VAR_SEQ 177 178 Missing (in isoform 3).
{ECO:0000303|PubMed:11022042}.
/FTId=VSP_029173.
VAR_SEQ 219 262 Missing (in isoform 2).
{ECO:0000303|Ref.2}.
/FTId=VSP_023769.
MUTAGEN 25 26 DL->AS: Abolishes binding to CTBP1 and
impairs function in transcription
repression.
{ECO:0000269|PubMed:11022042}.
CONFLICT 120 120 R -> K (in Ref. 2; AAK15027/AAL86358).
{ECO:0000305}.
CONFLICT 136 136 R -> K (in Ref. 2; AAK15027/AAL86358).
{ECO:0000305}.
CONFLICT 388 388 N -> T (in Ref. 3; AAH98187).
{ECO:0000305}.
CONFLICT 523 523 N -> T (in Ref. 1; AAG48332).
{ECO:0000305}.
HELIX 143 153 {ECO:0000244|PDB:1TQE}.
SEQUENCE 588 AA; 65687 MW; 4ED7FA9F02BD4621 CRC64;
MHSMISSVDV KSEVPMGLEP ISPLDLRTDL RMMMPVVDPV VREKQLQQEL LLIQQQQQIQ
KQLLIAEFQK QHENLTRQHQ AQLQEHIKEL LAIKQQQELL EKEQKLEQQR QEQEVERHRR
EQQLPPLRGK DRGRERAVAS TEVKQKLQEF LLSKSATKDT PTNGKNHSVG RHPKLWYTAA
HHTSLDQSSP PLSGTSPSYK YTLPGAQDSK DDFPLRKTAS EPNLKVRSRL KQKVAERRSS
PLLRRKDGNL VTSFKKRVFE VAESSVSSSS PGSGPSSPNN GPAGNVTENE ASALPPTPHP
EQLVPQQRIL IHEDSMNLLS LYTSPSLPNI TLGLPAVPSP LNASNSLKDK QKCETQMLRQ
GVPLPSQYGS SIAASSSHVH VAMEGKPNSS HQALLQHLLL KEQMRQQKLL VAGGVPLHPQ
SPLATKERIS PGIRGTHKLP RHRPLNRTQS APLPQSTLAQ LVIQQQHQQF LEKQKQYQQQ
IHMNKLLSKS IEQLKQPGSH LEEAEEELQG DQSMEDRAAS KDNSARSDSS ACVEDTLGQV
GAVKVKEEPV DSDEDAQIQE MECGEQAAFM QQVIGKDLAP GFVIKVII
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Pathways :
WP1211: Arylamine metabolism
WP1619: Amino sugar and nucleotide sugar metabolism
WP2361: Gastric cancer network 1
WP2366: Butyrate-induced histone acetylation
WP2369: Histone modifications
WP300: Histone modifications
WP694: Arylamine metabolism
WP875: Arylamine metabolism
WP993: Arylamine metabolism
WP1502: Mitochondrial biogenesis
WP2199: Seed Development
WP2272: Pathogenic Escherichia coli infection
WP731: Sterol regulatory element binding protein related
WP1049: G Protein Signaling Pathways
WP1066: Eukaryotic Transcription Initiation
WP1165: G Protein Signaling Pathways
WP1182: Eukaryotic Transcription Initiation
WP1238: Eukaryotic Transcription Initiation
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1497: Hedgehog-related genes
WP1531: Vitamin D synthesis
WP1541: Energy Metabolism
WP1559: TFs Regulate miRNAs related to cardiac hypertrophy
Related Genes :
[HIST1H3A H3FA; HIST1H3B H3FL; HIST1H3C H3FC; HIST1H3D H3FB; HIST1H3E H3FD; HIST1H3F H3FI; HIST1H3G H3FH; HIST1H3H H3FK; HIST1H3I H3FF; HIST1H3J H3FJ] Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l)
[HIST1H2BC H2BFL; HIST1H2BE H2BFH; HIST1H2BF H2BFG; HIST1H2BG H2BFA; HIST1H2BI H2BFK] Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)
[HIST1H2AB H2AFM; HIST1H2AE H2AFA] Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)
[HIST1H1C H1F2] Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1)
[HIST1H1B H1F5] Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3)
[H1F0 H1FV] Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed]
[HIST2H3A; HIST2H3C H3F2 H3FM; HIST2H3D] Histone H3.2 (Histone H3/m) (Histone H3/o)
[EHMT2 BAT8 C6orf30 G9A KMT1C NG36] Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)
[Ehmt2 Bat8 G9a Ng36] Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a)
[HIST2H2AC H2AFQ] Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)
[KAT2A GCN5 GCN5L2] Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (hGCN5) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)
[HIST1H2AD H2AFG] Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)
[HIST2H2AA3 H2AFO HIST2H2AA; HIST2H2AA4] Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)
[EP300 P300] Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-)
[HHT1 TTHERM_00570560; HHT2 TTHERM_00189180] Histone H3 (H3S) (Histone H3-I/H3-II) (Major histone H3) [Cleaved into: H3F]
[EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D] Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D)
[H2AFY MACROH2A1] Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205)
[HIST1H2BD H2BFB HIRIP2] Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)
[HIST2H2BE H2BFQ] Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)
[HIST1H2BJ H2BFR] Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)
[HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR] Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR)
[Kat2a Gcn5l2] Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (MmGCN5) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A)
[HIST1H2BB H2BFF] Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)
[Ep300 P300] Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-)
[HIST1H2BO H2BFH H2BFN] Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)
[HIST1H2BA TSH2B] Histone H2B type 1-A (Histone H2B, testis) (TSH2B.1) (hTSH2B) (Testis-specific histone H2B)
[Hist1h2ba Th2b] Histone H2B type 1-A (Histone H2B, testis) (Testis-specific histone H2B)
[] Histone H3.3 (Histone H3.2) (Minor histone H3)
[KAT2B PCAF] Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF)
[Hdac9 Hdac7b Hdrp Mitr] Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR)
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits